Topf

Newer Anemia Therapies

January 10, 2012 // 1 Comment

The management of anemia associated with kidney disease is undergoing a revolution as the safety of erythropoietin analogs is being challenged by newly recognized dangers including cardiovascular disease, strokes, access failures and malignancy. [read more...]